Structural features and classification
By its chemical structure, daclizumab (Daclizumabum) belongs to humanized monoclonal antibodies. This molecule combines a protein structure of 90% human origin, while the remaining 10% are murine components. This hybrid structure provides the required binding specificity.
Mechanism of pharmacological action
The main objective of the drug is to target specific links of the immune system:
- The substance selectively binds to interleukin-2 (IL-2) receptors.
- The targets are exclusively activated T-lymphocytes.
- Effective blockade of the cellular immune response activation occurs, which is critically important during organ transplantation.
Pharmacokinetics and dosing regimens
The drug is prescribed for parenteral administration and has a strict dosing schedule:
- Route of administration: intravenous only.
- The course therapy consists of 5 consecutive doses.
- The first dose is administered exactly 24 hours before the transplantation procedure.
- Subsequent doses are administered at a fixed interval of 14 days.
- Once administered, a single dose provides prolonged blockade of the corresponding receptors for up to 120 days.
Safety profile and adverse effects
In general, daclizumab is characterized as a relatively non-toxic medicinal product. However, various adverse reactions may develop during pharmacotherapy:
- Gastrointestinal: primary disorders of the digestive system predominate.
- Systemic manifestations: headache, elevated body temperature (fever), pronounced tremor, and sleep disorders (insomnia) may occur.
- Cardiovascular effects: blood pressure fluctuations in the form of hypertension or hypotension, palpitations (tachycardia), as well as lower extremity and pulmonary edema.
- Other reactions: risk of infectious complications, shortness of breath, elevated blood sugar levels (hyperglycemia), as well as muscle and joint pain (myalgia and arthralgia).
Briefly: answers to topical questions
What are the official International Nonproprietary Names (INN) of daclizumab analogs?
The provided materials indicate basiliximab as a drug with a mechanism of action analogous to daclizumab. The indications, mechanism of action, and side effects of basiliximab are completely identical to those of daclizumab.
| Characteristic | Daclizumab | Basiliximab |
|---|---|---|
| Structure | Humanized monoclonal antibodies (90% human, 10% murine) | Chimeric monoclonal antibodies (75% human, 25% murine) |
| Activity | — | 10-fold superior to daclizumab |
| Mechanism of action | Blocks IL-2 receptors (CD25) on T-lymphocytes | Blocks IL-2 receptors (CD25) on T-lymphocytes |
Dac-"LIZ"-umab lyses the activity of activated T-lymphocytes by blocking IL-2 for exactly 120 days (5 doses on schedule).
Class and exam questions
What class of substances does daclizumab belong to?
The drug is a humanized monoclonal antibody consisting of 90% human and 10% murine protein structures.
What is the standard course of administration for the drug?
The therapeutic course includes 5 doses. The first dose is administered 24 hours before transplantation, and subsequent ones at two-week intervals.
Which cells and receptors are targeted by the mechanism of action?
Daclizumab binds to interleukin-2 (IL-2) receptors located on the surface of already activated T-lymphocytes, thereby blocking cellular immunity.
What else to study on this topic
- Comparative characteristics of humanized and chimeric monoclonal antibodies
- Pathophysiology of cellular immune response in transplantation
- Criteria for evaluating infectious complications against the background of immunosuppression
- Features of blood pressure correction and edema syndrome
- Pharmacoeconomics of course administration of monoclonal antibodies
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Daclizumab" and 5,304 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Agents Regulating Immune Processes"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.